RKDA
RKDA
NASDAQ · Food Products

Arcadia Biosciences Inc

$1.07
+0.01 (+0.94%)
As of May 16, 2:35 AM ET ·
Financial Highlights (FY 2026)
Revenue
6.49M
Net Income
-3,124,563
Gross Margin
36.2%
Profit Margin
-48.2%
Rev Growth
-21.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 36.2% 36.2% 64.9% 64.9%
Operating Margin -51.5% -46.3% 14.7% 13.5%
Profit Margin -48.2% -45.7% 14.8% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.49M 8.24M 1.13M 1.01M
Gross Profit 2.35M 2.99M 731.9K 656.9K
Operating Income -3,339,564 -3,818,099 165.1K 136.9K
Net Income -3,124,563 -3,572,290 167.1K 122.6K
Gross Margin 36.2% 36.2% 64.9% 64.9%
Operating Margin -51.5% -46.3% 14.7% 13.5%
Profit Margin -48.2% -45.7% 14.8% 12.1%
Rev Growth -21.3% -21.3% -3.2% +0.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.55M 1.44M
Total Equity 1.12M 1.03M
D/E Ratio 1.38 1.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,551,037 -7,905,850 233.2K 200.7K
Free Cash Flow 165.9K 91.6K